Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A refined coadministration regime to mitigate immunological clearance of biomedical nanoparticles.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026

Same author

Coumarin-Caged Nanoparticle for Light-Driven Surface Modification.

ChemMedChem·2025

Same author

Interprofessional Therapeutic Drug Monitoring of Piperacillin/Tazobactam Enhances Care for Patients with Acute-on-Chronic Liver Failure in the ICU: A Retrospective Observational Pilot Study.

Antibiotics (Basel, Switzerland)·2025

Same author

The quantity of ligand-receptor interactions between nanoparticles and target cells.

Nanoscale horizons·2025

Same author

Interprofessional approach to personalized medication management and therapy optimization in IBD care.

Frontiers in medicine·2025

Same author

Control of biomedical nanoparticle distribution and drug release in vivo by complex particle design strategies.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2025

Search research articles

Related Experiment Video

Updated: Dec 7, 2025

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Biomedical nanoparticle design: What we can learn from viruses.

Sara Maslanka Figueroa¹, Daniel Fleischmann¹, Achim Goepferich¹

¹Department of Pharmaceutical Technology, University of Regensburg, Universitaetsstrasse 31, 93053 Regensburg, Germany.

Journal of Controlled Release : Official Journal of the Controlled Release Society

|October 2, 2020

Summary

Viruses offer superior nanomaterial properties for biomedical uses. Mimicking viral traits in synthetic nanoparticles (NPs) can enhance targeting efficiency and therapeutic applications.

Keywords:

Nanoparticles Targeting Virus-mimetic

More Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Related Experiment Videos

Last Updated: Dec 7, 2025

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Area of Science:

Biomedical Engineering
Nanotechnology
Virology

Background:

Viruses possess unique nanomaterial properties exceeding synthetic nanoparticles (NPs) for biomedical applications.
Viral attributes include ordered structure, diverse shapes, unique surface elements (spikes), and specific cellular interactions.
These properties facilitate biodistribution, barrier crossing, and immune evasion, enhancing therapeutic potential.

Purpose of the Study:

To comprehensively evaluate the impact of virus-mimetic material design on nanomaterial targeting efficiency.
To review design strategies for creating virus-mimetic nanomaterials.
To discuss the advantages and future perspectives of virus-mimetic approaches in nanomedicine.

Main Methods:

Literature review focusing on virus-mimetic nanomaterial design.
Analysis of viral properties and their translation to synthetic nanomaterials.
Evaluation of targeting efficiency and practical considerations.

Main Results:

Viruses exhibit superior properties like specific targeting, immune evasion, and stimuli-responsive behavior.
Mimicking viral traits can significantly improve nanomaterial performance in biomedical applications.
Existing literature lacks a comprehensive evaluation of virus-mimetic design's impact on targeting efficiency.

Conclusions:

Virus-mimetic design holds significant promise for enhancing nanoparticle targeting in biomedical applications.
Further research and development are needed to translate these strategies into clinical practice.
Viral mimicry may be key to achieving precise and effective nanoparticle delivery.